Infection, Immunity and Vaccines

Date:	November 16, 2017   |   8:30 am – 5:00 pm November 17, 2017    |   8:30 am – 3:30 pm
Location:	The Menger Hotel 204 Alamo Plaza San Antonio, TX 78205

2017 Event Flyer
2017 Event Schedule

---

Registration Click here to register.	Poster Requirements » Poster size: 36″ x 36″ or 36″ x 48″ or 36″ x 54″ » Must have at least two (2) authors » Abstract limited to 250 words maximum » May use either results or methodology
Abstract Deadline: November 5, 2017
Registration Deadline: November 12, 2017
Accommodations Click here to book a room at the Menger Hotel. Group Code: 111417VACCIN

---

 

Keynote Speakers

TBD

Dr. William Bishai, Professor and Co-Director, Center for Tuberculosis Research, Johns Hopkins School of Medicine

Dr. Bishai is interested in the molecular pathogenesis of tuberculosis. A theme of his research has been to assess mycobacterial genes important in gene regulation. Other active interests include cell division in mycobacteria and the pathogenesis of caseation and cavitation. His research program goals are first to better understand tuberculosis pathogenesis, and then to employ this understanding towards improved drugs, vaccines, and diagnostics.

Dr. Bishai received his Ph.D. and his M.D. from Harvard Medical School.

 

Vaccine Preventable Zoonoses: Getting Ahead of the Curve

Dr. Jennifer McQuiston, Deputy Director, Centers for Disease Control and Prevention Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases

Dr. McQuiston specializes in outbreak investigations and research involving diseases that spread from animals to people. She has worked on diseases such as Rocky Mountain spotted fever, Q fever, and rabies. Her interests include diseases transmitted to humans by ticks, fleas, and livestock.

Dr. McQuiston received her DVM from the Virginia-Maryland Regional College of Veterinary Medicine.

 

Clinical Assessment of DNA Vaccines for Hemorrhagic Fever with Renal Syndrome

Dr. Connie Schmaljohn, Senior Research Scientist, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)

An internationally recognized expert on hantaviruses and hemorrhagic fever with renal syndrome, Dr. Schmaljohn uses molecular biology tools to develop and test vaccines for a range of viruses. Her lab works on two types of vaccines: those that protect against medical infectious diseases and those that defend against agents that could be used as weapons in biological warfare.

Dr. Schmaljohn received her Ph.D. from Colorado State University.

 

Ubiquitin-Dependent Regulation of T Cell Responses in Autoimmunity and Antitumor Immunity

Dr. Shao-Cong Sun, Professor, Moshe Talpaz Endowed Chair in Immunology, and Director of the Center for Inflammation and Cancer, University of Texas MD Anderson Cancer Center

Dr. Sun has been studying signal transduction in the immune and inflammatory responses for more than twenty years, with a major focus on the regulation of inflammatory T-cell activation and differentiation. An important part of his lab’s ongoing research is to dissect the ubiquitin-dependent signaling pathways in the regulation of inflammatory T cell function in inflammation and inflammation-associated cancer.

Dr. Sun received his Ph.D. in Microbiology from Stockholm University.

 

How Gut Microbiota Impact Gut-Distal Autoimmune Disease

Dr. Hsin-Jung Joyce Wu, Assistant Professor, Department of Immunobiology, The University of Arizona College of Medicine

Dr. Wu’s current research includes dysregulation of immunity and inflammation, Immunotherapy and immune intervention, and microbial pathogenesis and commensalism. These research areas are dedicated to the understanding of how commensal bacteria influence the inflammatory and immune response mediated by autoimmune disease. The goal of this work is focused on exploring the link between gut microbiota, mucosal immunity, and autoimmune arthritis.

Dr. Wu received her Ph.D. from the University of Kentucky.